Bambusa Therapeutics
Clinical trials sponsored by Bambusa Therapeutics, explained in plain language.
-
New eczema drug enters first human tests
Symptom relief Recruiting nowThis early-stage study tests a new drug called BBT001 in healthy volunteers and adults with moderate-to-severe eczema (atopic dermatitis). The main goal is to check safety and how the body handles the drug. About 198 people will take part, and some will receive a placebo. This is…
Phase: PHASE1 • Sponsor: Bambusa Therapeutics • Aim: Symptom relief
Last updated May 26, 2026 04:47 UTC
-
New COPD drug BBT002 enters first human safety trials
Symptom relief Recruiting nowThis early-stage study tests a new drug, BBT002, in healthy people and those with COPD to see if it is safe and how the body handles it. About 68 participants will receive either the drug or a placebo. The main goal is to check for side effects, not yet to prove it works.
Phase: PHASE1 • Sponsor: Bambusa Therapeutics • Aim: Symptom relief
Last updated May 26, 2026 04:34 UTC
-
New eczema drug enters first human tests
Symptom relief Recruiting nowThis early-stage study tests a new drug called BBT001 in healthy volunteers and adults with moderate-to-severe atopic dermatitis (eczema). The main goal is to check safety and how the body handles the drug. About 63 people will take part, and some will receive a placebo. This is …
Phase: PHASE1 • Sponsor: Bambusa Therapeutics • Aim: Symptom relief
Last updated May 20, 2026 11:56 UTC